Similar articles

• Interferon clearance rate decreased after repeated injections.

  Nuwer MR, De Clercq E, Merigan TC. Nuwer MR, et al. J Gen Virol. 1971 Aug;12(2):191-4. doi: 10.1099/0022-1317-12-2-191. J Gen Virol. 1971. PMID: 4330791 No abstract available.
• The kinetics of human interferon clearance in gibbons.

  Skreko F, Zajac I, Bahnsen HP, Haff RF, Cantell K. Skreko F, et al. Proc Soc Exp Biol Med. 1973 Mar;142(3):946-7. doi: 10.3181/00379727-142-37151. Proc Soc Exp Biol Med. 1973. PMID: 4692028 No abstract available.
• Circulating interferon in man after administration of exogenous human leukocyte interferon.

  Emödi G, Just M, Hernandez R, Hirt HR. Emödi G, et al. J Natl Cancer Inst. 1975 May;54(5):1045-9. J Natl Cancer Inst. 1975. PMID: 1127735
• Evaluation of routes of administration of interferon in cancer: a review and a proposal.

  Bocci V. Bocci V. Cancer Drug Deliv. 1984 Fall;1(4):337-51. doi: 10.1089/cdd.1984.1.337. Cancer Drug Deliv. 1984. PMID: 6085757 Review.
• Human leukocyte interferon: production, purification, stability, and animal experiments.

  Cantell K, Hirvonen S, Mogensen KE, Pyhälä L. Cantell K, et al. In Vitro Monogr. 1974;(3):35-8. In Vitro Monogr. 1974. PMID: 4620359 Review. No abstract available.